Header cover image

German (DAX) Clinical Research and Equipment Industry Analysis

UpdatedSep 06, 2024
DataAggregated Company Financials
Companies4
  • 7D-4.4%
  • 3M-1.0%
  • 1Y-35.8%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 4.4%, driven by a pullback from SCHOTT Pharma KGaA of 4.7%. Overall the industry is down 36% in 12 months. Earnings are forecast to grow by 29% annually.

Industry Valuation and Performance

Has the German Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 07 Sep 2024€24.3b€7.1b€172.8m34.2x140.9x3.4x
Mon, 05 Aug 2024€25.0b€7.0b€237.1m35.7x105.3x3.5x
Wed, 03 Jul 2024€23.1b€7.0b€309.8m35.1x74.4x3.3x
Fri, 31 May 2024€24.3b€7.0b€333.3m30.3x73x3.5x
Sun, 28 Apr 2024€29.0b€7.0b€340.1m37.9x85.2x4.1x
Tue, 26 Mar 2024€34.2b€7.1b€384.5m37.7x88.9x4.8x
Thu, 22 Feb 2024€31.7b€7.1b€369.5m36.7x85.8x4.5x
Sat, 20 Jan 2024€28.7b€7.3b€507.1m33.6x56.6x3.9x
Mon, 18 Dec 2023€32.6b€7.3b€507.1m34.4x64.2x4.5x
Wed, 15 Nov 2023€27.2b€7.3b€507.1m29.5x53.6x3.7x
Fri, 13 Oct 2023€26.6b€6.6b€498.8m38.7x53.2x4x
Sun, 10 Sep 2023€29.1b€6.6b€498.1m42.2x58.5x4.4x
Tue, 08 Aug 2023€29.4b€6.6b€425.8m41.1x69.1x4.5x
Thu, 06 Jul 2023€27.5b€6.7b€487.3m38.2x56.3x4.1x
Sat, 03 Jun 2023€28.2b€6.7b€487.3m39.1x57.8x4.2x
Mon, 01 May 2023€28.0b€6.7b€483.0m38.8x58x4.2x
Wed, 29 Mar 2023€31.0b€6.7b€594.3m35.6x52.2x4.6x
Fri, 24 Feb 2023€31.9b€6.6b€588.7m35.2x54.2x4.8x
Sun, 22 Jan 2023€30.9b€6.5b€447.4m37.5x69x4.8x
Tue, 20 Dec 2022€26.9b€6.5b€447.4m32.6x60x4.2x
Thu, 17 Nov 2022€29.4b€6.5b€447.4m36.2x65.6x4.5x
Sat, 15 Oct 2022€28.1b€6.2b€573.0m52.2x49x4.5x
Mon, 12 Sep 2022€5.7b€2.3b€84.0m1257.2x67.9x2.5x
Wed, 10 Aug 2022€6.7b€2.3b€171.9m38.5x39.2x3x
Fri, 08 Jul 2022€6.3b€2.2b€174.9m35.7x36.1x2.8x
Sun, 05 Jun 2022€6.7b€2.2b€173.3m38.2x38.9x3x
Tue, 03 May 2022€6.1b€2.2b€299.3m21.4x20.5x2.8x
Thu, 31 Mar 2022€7.1b€2.1b€329.6m22.6x21.5x3.4x
Sat, 26 Feb 2022€6.8b€2.1b€342.9m18.4x19.9x3.3x
Mon, 24 Jan 2022€8.9b€2.0b€345.9m25.4x25.6x4.3x
Wed, 22 Dec 2021€10.1b€2.0b€345.8m27.9x29.2x4.9x
Fri, 19 Nov 2021€10.3b€2.0b€345.7m29.3x29.7x5x
Sun, 17 Oct 2021€9.6b€2.0b€216.7m29x44.3x4.8x
Tue, 14 Sep 2021€10.5b€2.0b€222.8m30.3x46.9x5.3x
Price to Earnings Ratio

46.9x


Total Market Cap: €10.5bTotal Earnings: €222.8mTotal Revenue: €2.0bTotal Market Cap vs Earnings and Revenue0%0%0%
German Clinical Research and Equipment Industry Price to Earnings3Y Average 57x202220232024
Current Industry PE
  • Investors are optimistic on the German Life Sciences Tools and Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 141x which is higher than its 3-year average PE of 56.9x.
  • The 3-year average PS ratio of 4.0x is higher than the industry's current PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have declined 8.1% per year over the last three years.
  • Meanwhile revenues for these companies have grown 53% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does German Clinical Research and Equipment compare with similar industries?

DE Market-1.56%
Healthcare-1.88%
Life Sciences-4.41%
Clinical Research and Equipment-4.41%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

1SXP

€33.98

SCHOTT Pharma KGaA

7D

-5.6%

1Y

n/a

EVT

€5.94

Evotec

7D

-11.0%

1Y

-72.1%